Molecular manipulations of the multidrug transporter: a new role for transgenic mice
- PMID: 1868977
- DOI: 10.1096/fasebj.5.11.1868977
Molecular manipulations of the multidrug transporter: a new role for transgenic mice
Abstract
Multidrug resistance in human cancer is associated with overexpression of the MDR1 gene which encodes a 170,000 molecular weight membrane glycoprotein that transports cytotoxic drugs out of cancer cells. The MDR1 gene is normally expressed in intestine, kidney, liver, and adrenal glands, and in tumors derived from these tissues, but it is not expressed in normal bone marrow. Transgenic mice that express the MDR1 gene in their bone marrow have been developed, and because of this expression these mice are resistant to the bone marrow-suppressive effects of daunomycin, doxorubicin, taxol, and several other anticancer drugs. These mice can be used in several different ways to develop new types of drugs to treat human cancer.--Pastan, I.; Willingham, M. C.; Gottesman, M. Molecular manipulations of the multidrug transporter: a new role for transgenic mice.
Similar articles
-
Chemotherapy and chemosensitization of transgenic mice which express the human multidrug resistance gene in bone marrow: efficacy, potency, and toxicity.Cancer Res. 1991 Oct 1;51(19):5417-24. Cancer Res. 1991. PMID: 1680550
-
Transgenic mice that express the human multidrug-resistance gene in bone marrow enable a rapid identification of agents that reverse drug resistance.Proc Natl Acad Sci U S A. 1991 Jan 15;88(2):547-51. doi: 10.1073/pnas.88.2.547. Proc Natl Acad Sci U S A. 1991. PMID: 1671173 Free PMC article.
-
Transplantation of bone marrow cells from transgenic mice expressing the human MDR1 gene results in long-term protection against the myelosuppressive effect of chemotherapy in mice.Blood. 1992 Feb 15;79(4):1087-93. Blood. 1992. PMID: 1737094
-
Multidrug resistant transgenic mice as a novel pharmacologic tool.Bioessays. 1991 Aug;13(8):381-7. doi: 10.1002/bies.950130804. Bioessays. 1991. PMID: 1683231 Review.
-
From laboratory expertise to clinical practice: multidrug-resistance-based gene therapy becomes available for urologists.World J Urol. 1994;12(2):104-11. doi: 10.1007/BF00184246. World J Urol. 1994. PMID: 8087140 Review.
Cited by
-
Drug-stimulated ATPase activity of the human P-glycoprotein.J Bioenerg Biomembr. 1995 Feb;27(1):37-41. doi: 10.1007/BF02110329. J Bioenerg Biomembr. 1995. PMID: 7629050 Review.
-
MDR1 and ERCC1 expression predict outcome of patients with locally advanced bladder cancer receiving adjuvant chemotherapy.Neoplasia. 2010 Aug;12(8):628-36. doi: 10.1593/neo.10402. Neoplasia. 2010. PMID: 20689757 Free PMC article. Clinical Trial.
-
Novobiocin modulates colchicine sensitivity in parental and multidrug-resistant B16 melanoma cells.J Cancer Res Clin Oncol. 1994;120(10):599-604. doi: 10.1007/BF01212814. J Cancer Res Clin Oncol. 1994. PMID: 7929531 Free PMC article.
-
Increased doxorubicin levels in hepatic tumors with reduced systemic drug exposure achieved with complete hepatic venous isolation and extracorporeal chemofiltration.Cancer Chemother Pharmacol. 1993;33(3):251-7. doi: 10.1007/BF00686224. Cancer Chemother Pharmacol. 1993. PMID: 8269607
-
Osmotic opening of the blood-brain barrier: principles, mechanism, and therapeutic applications.Cell Mol Neurobiol. 2000 Apr;20(2):217-30. doi: 10.1023/a:1007049806660. Cell Mol Neurobiol. 2000. PMID: 10696511 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
